Closing the Gap in Care in Seronegative Inflammatory Arthritis (Metrix II)

Pope Research

Status: Completed

Conditions: SpA; PsA

Treatments: Behavioral: Education and Feedback

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01749618

Metrix II

Details and patient eligibility

About

Rheumatologists treating patients with seronegative arthritis will be randomized to treat their patients to a target or to treat their patients under their usual standard of care. All physicians will perform an initial chart audit. Following the initial chart audit, all physicians in the treat-to-target group will receive accredited educational training. Six months after the initial chart audit, all physicians will perform a repeat audit to see if patients are assessed more systematically and treated to a target of low disease state.

Enrollment: 40 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Canadian Rheumatologist

Exclusion Criteria:

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

No education or feedback

No Intervention group

Description:

Rheumatologists randomized to this treatment arm receive no additional education or feedback about their systematic assessments of patients

Education and Feedback

Experimental group

Description:

Rheumatologists randomized to receive education and feedback participate in six web conferences designed to improve their systematic assessments of their patients, and are given feedback about their performances

Treatment:

Behavioral: Education and Feedback